Welcome to LookChem.com Sign In|Join Free

CAS

  • or

209224-95-3

4-bromo-2,3-dihydro-1H-indene-2-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

209224-95-3

Post Buying Request

209224-95-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

209224-95-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 209224-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,2,2 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 209224-95:
(8*2)+(7*0)+(6*9)+(5*2)+(4*2)+(3*4)+(2*9)+(1*5)=123
123 % 10 = 3
So 209224-95-3 is a valid CAS Registry Number.

209224-95-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromo-indane-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 4-bromo-indan-2-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:209224-95-3 SDS

209224-95-3Downstream Products

209224-95-3Relevant articles and documents

HCV NS3 PROTEASE INHIBITORS

-

Page/Page column 52-53, (2008/12/05)

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

-

Page/Page column 27; 28, (2008/12/04)

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.

Pyrazole derivatives

-

, (2008/06/13)

The present invention relates to a compound represented by the general formula [I]: wherein A and B rings are ortho-condensed to each other, A ring represents an aromatic carbocyclic or heterocyclic ring and B ring represents an aliphatic four- to seven-m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 209224-95-3